A2A Pharmaceuticals, Inc. 4
4 · Biomea Fusion, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-04-20$29.12/sh−200,000$5,823,760→ 3,900,000 total
Footnotes (1)
- [F1]A total of 200,000 shares were sold at an average price of 29.1188 in multiple transactions in a range of 28.85 to 29.495. Details of the specific transactions are available upon request